SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001564590-21-012120
Filing Date
2021-03-10
Accepted
2021-03-10 17:26:44
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 xene-424b5.htm 424B5 1230822
2 GRAPHIC gpnjef3lmu5l000001.jpg GRAPHIC 10178
3 GRAPHIC gpnjef3lmu5l000003.jpg GRAPHIC 10178
4 GRAPHIC gpnjef3lmu5l000002.jpg GRAPHIC 13213
  Complete submission text file 0001564590-21-012120.txt   1278483
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-238896 | Film No.: 21730937
SIC: 2834 Pharmaceutical Preparations